% alzhub.org library filter
% Source: https://alzhub.org/research?author=Bentham+P&access=free
% 3 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{wischik2015-25550228,
  author  = {Wischik, C. M. and Staff, R. T. and Wischik, D. J. and Bentham, P. and Murray, A. D. and Storey, J. M. and Kook, K. A. and Harrington, C. R.},
  title   = {{Tau aggregation inhibitor therapy: an exploratory phase 2 study in mild or moderate Alzheimer's disease}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2015},
  doi     = {10.3233/jad-142874},
  pmid    = {25550228},
  url     = {https://doi.org/10.3233/jad-142874}
}

@article{banerjee2011-21764118,
  author  = {Banerjee, S. and Hellier, J. and Dewey, M. and Romeo, R. and Ballard, C. and Baldwin, R. and Bentham, P. and Fox, C. and others},
  title   = {{Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial}},
  journal = {Lancet (London, England)},
  year    = {2011},
  doi     = {10.1016/s0140-6736(11)60830-1},
  pmid    = {21764118},
  url     = {https://doi.org/10.1016/s0140-6736(11)60830-1}
}

@article{wischik2026-41570392,
  author  = {Wischik, C. M. and Stefanacci, R. and Bentham, P. and Gauthier, S. and Zetterberg, H. and Wilcock, G. K. and Froelich, L. and Burns, A. and MacSweeney, E. and Ballard, C. and others},
  title   = {{Clinical, imaging and blood biomarker outcomes in a Phase 3 clinical trial of tau aggregation inhibitor hydromethylthionine mesylate in mild cognitive impairment and mild to moderate dementia due to Alzheimer's disease}},
  journal = {The Journal of Prevention of Alzheimer's Disease},
  year    = {2026},
  doi     = {10.1016/j.tjpad.2026.100480},
  pmid    = {41570392},
  url     = {https://doi.org/10.1016/j.tjpad.2026.100480}
}